The safety profiles of the anti-programmed-cell death protein (PD)-1 and anti-programmed-cell death-protein–ligand (PD-L1) antibodies administered to patients with MCC appear similar to those observed in previous trials involving patients with other tumor entities [4]. Here, CD274 is linked to Merkel cell skin cancer.